<TABLE> <S> <C>

<ARTICLE>                                  5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements included in the Form 10-QSB of Endogen, Inc. to which this
exhibit is a part and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<RESTATED>
<CIK>                                      0000894020
<NAME>                                     Endogen, Inc.
<MULTIPLIER>                               1,000
<CURRENCY>                                 U.S. Dollars
       
<S>                                        <C>
<PERIOD-TYPE>                              9-mos
<FISCAL-YEAR-END>                          May-31-1996
<PERIOD-START>                             Jun-01-1995
<PERIOD-END>                               Feb-29-1996
<EXCHANGE-RATE>                                                    1.00
<CASH>                                                              744
<SECURITIES>                                                          0
<RECEIVABLES>                                                     1,106
<ALLOWANCES>                                                         20
<INVENTORY>                                                       1,109
<CURRENT-ASSETS>                                                  3,074
<PP&E>                                                            1,672
<DEPRECIATION>                                                      763
<TOTAL-ASSETS>                                                    4,459
<CURRENT-LIABILITIES>                                               723
<BONDS>                                                               0
<PREFERRED-MANDATORY>                                                 0
<PREFERRED>                                                           0
<COMMON>                                                             29
<OTHER-SE>                                                        3,683
<TOTAL-LIABILITY-AND-EQUITY>                                      4,459
<SALES>                                                           4,410
<TOTAL-REVENUES>                                                  4,410
<CGS>                                                             1,476
<TOTAL-COSTS>                                                     4,229
<OTHER-EXPENSES>                                                      0
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                    0
<INCOME-PRETAX>                                                     186
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                                 186
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                        186
<EPS-PRIMARY>                                                       .07
<EPS-DILUTED>                                                       .06
        

</TABLE>